Home › Funds › SATURNA CAPITAL CORP › JNJ

SATURNA CAPITAL CORP position in JNJ

JOHNSON JOHNSON · Health Care

SATURNA CAPITAL CORP reported holding 229,115 shares of JNJ (JOHNSON JOHNSON) in its Q2 2026 13F filing — a position valued at US$58.2M, representing 0.71% of its reported portfolio and ranking #32 among its reported holdings. SATURNA CAPITAL CORP has disclosed JNJ holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)229.12K sh
Reported value held$58.19M
Portfolio Weight0.71%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How SATURNA CAPITAL CORP's JNJ position evolved

SATURNA CAPITAL CORP first disclosed a stake in JNJ in Q3 2023 at 541,477 shares (US$84.3M). Across 12 filings, SATURNA CAPITAL CORP increased the stake 1 time(s), trimmed it 5 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 229,115 shares valued at US$58.2M — an increase of 49,938 shares quarter over quarter.. Notable position changes include a 65% trim in Q1 2024 (shares fell 8% over the following quarter), a 28% increase in Q2 2026 (shares rose 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 541.48K $84.34M New
Q4 2023 524.57K $82.22M Reduce
Q1 2024 183.93K $29.10M Reduce
Q2 2024 184.60K $26.98M Hold
Q3 2024 185.34K $30.04M Hold
Q4 2024 182.64K $26.41M Reduce
Q1 2025 182.59K $30.28M Hold
Q2 2025 182.40K $27.86M Hold
Q3 2025 182.08K $33.76M Hold
Q4 2025 180.90K $37.44M Reduce
Q1 2026 179.18K $43.80M Reduce
Q2 2026 229.12K $58.19M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON JOHNSON) is a Health Care company. 33 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has SATURNA CAPITAL CORP held JNJ?

SATURNA CAPITAL CORP has disclosed JNJ holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is SATURNA CAPITAL CORP's current position in JNJ?

As of Q2 2026, SATURNA CAPITAL CORP holds 229.12K shares of JNJ (JOHNSON JOHNSON), valued at $58.19M, representing 0.71% of its reported portfolio and ranking #32.

Has SATURNA CAPITAL CORP been buying or selling JNJ?

In the latest 13F filing (Q2 2026), SATURNA CAPITAL CORP increased its position in JNJ.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.